First-generation antipsychotic (phenothiazine)
Pericyazine
Brand names: Neulactil
Adult dose
Dose: Schizophrenia: 75mg/day in divided doses initially, max 300mg/day. Adjunct in severe anxiety/disturbed behaviour: 15–30mg/day in divided doses
Route: PO
Frequency: divided
Clinical pearls
- Less commonly used; high anticholinergic burden
- Avoid in elderly with dementia
Contraindications
- CNS depression
- Phaeochromocytoma
- Bone marrow depression
Side effects
- Sedation
- Anticholinergic effects
- Postural hypotension
- Extrapyramidal effects
- QT prolongation
- Hyperprolactinaemia
Interactions
- CNS depressants
- QT-prolonging drugs
- Antimuscarinics
- Levodopa
Monitoring
- BP
- ECG
- Glucose
- Lipids
- Prolactin
Reference: BNF; NICE CG178; https://bnf.nice.org.uk/drugs/pericyazine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF